Report Scope:
This research study analyzes the PCR market, offers revenue forecasts, assesses future trends, and provides strategic recommendations for the success of market participants. The scope of the study is global. This report estimates market data for 2022 (the base year) and forecasts for 2023 through 2028. Figures for 2023 are estimated, except where actual results are reported. This report includes forecasts by product type, technique, application, and region from 2023 through 2028.

The report also analyzes leading and emerging competitors in the current worldwide PCR market.

Report Includes:

  • 49 data tables and 65 additional tables
  • An overview and up-to-date analysis of the global markets for the polymerase chain reaction (PCR) technologies
  • Analyses of the global market trends, with historical market revenue data (sales figures) from 2021 to 2022, estimates for 2023, forecasts for 2024, and projections of compound annual growth rates (CAGRs) through 2028
  • Estimate of the actual market size and revenue forecast for the PCR markets in USD millions, and corresponding market share analysis based on product, technique, application, and region
  • In-depth information (facts and figures) pertaining to the major market dynamics, R&D efforts, current status on MedTech, upcoming technologies, future demand in clinical diagnostics, and regulatory scenarios; and the impacts of COVID-19 pandemic on the worldwide market
  • Identification of the companies that are best positioned to meet the surging demand for innovations in PCR technology, owing to or in conjunction with their proprietary technologies, strategic alliances, and other competitive advantages
  • Discussion of sustainability trends and factors in emerging materials in the PCR market, with emphasis on consumer attitudes, ESG score analysis, future of ESG, and the ESG practices followed
  • An overview of the major vendors in the global PCR market along with an analysis of the structure of the industry, including company market shares and recent mergers and acquisitions (M&A) activity
  • Review of both new and existing patents on PCR technologies and their applications in molecular diagnosis of infectious diseases
  • Profiles of the leading global players, including F. Hoffmann-LaRoche, Thermo Fisher Scientific Inc., Bio-Rad Laboratories Inc., Becton, Dickinson and Company, and Danaher Corp.